Noah Auerhahn net worth
Quick answer
Noah Auerhahn's estimated net worth is $10.0M (range $7.0M – $15.0M) as of 2026. Noah Auerhahn is Founder at Uncommon Therapeutics. Uncommon Therapeutics valuation.
Noah Auerhahn is Founder at Uncommon Therapeutics (YC W25). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Region: United States of America
- Industries: Healthcare, Therapeutics
- Team size: 2
- Website: https://uncommontherapeutics.com
Who is Noah Auerhahn?
Noah Auerhahn is a founder known for his work at Uncommon Therapeutics, participating in Y Combinator's Winter 2025 batch.
Highlights:
- Y Combinator W25
About Uncommon Therapeutics
Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could be worth billions and together could deliver a cure.
FAQ: Noah Auerhahn net worth and Uncommon Therapeutics valuation
What is Noah Auerhahn's net worth?
Noah Auerhahn's estimated net worth is $10.0M (range $7.0M – $15.0M) as of 2026. Noah Auerhahn is Founder at Uncommon Therapeutics. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Uncommon Therapeutics valuation?
Uncommon Therapeutics's estimated valuation on Entrepreneurial Check is $20.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Noah Auerhahn's role?
Noah Auerhahn is Founder at Uncommon Therapeutics, a Y Combinator-backed startup (batch W25).